DeutschNewstral
Article
bizjournals.com on 2015-07-27 13:58
Teva drops bid for Mylan, buys Allergan's generic drug unit
Related news
- Teva drops bid for Mylan, buys Allergan's generic drug unit for $40.5 billionbizjournals.com
Teva drops bid for Mylan, buys Allergan generic drug company for $40.5 billionpost-gazette.com
Teva to buy Allergan generic drug business for $40.5-billion, drops Mylan bidThe Globe and Mail
Israel's Teva Buys Top Competitor Allergan's Generic Drug DistributorHaaretz- CIsrael's Teva buys Allergan generic drug company for $40.5Bcontracostatimes.com
Israel’s Teva drops bid for Mylan, buys Allergan for $40.5Btriblive.com
Israel’s Teva buys Allergan generic drug company for $40.5Breviewtimes.com
Israel’s Teva buys Allergan generic drug company for $40.5 billionpressherald.com
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bidReuters
Teva Pharmaceutical Industries to buy Allergan Plc’s generic drug business for US$40.5 billion, drops Mylan bidbusiness.financialpost.com- FAllergan sells generic drugs unit to Tevaft.com
Israel's Teva Pharmaceutical to buy Allergan's generic pharmaceuticals business for $40.5BTimesDaily.com
Source: Teva nears deal for Allergan's generic drugs unitThe Canadian Jewish News- Teva expands recall of generic cancer drugbizjournals.com